DOCSLIB.ORG

Overview of SNP Genotyping • Project Rationale

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Overview of SNP Genotyping • Project Rationale SNP Genotyping - Overview Overview of SNP Genotyping • Project Rationale • Genotyping Strategies/Technical Leaps Debbie Nickerson • Data Management/Quality Control Department of Genome Sciences University of Washington [email protected] SNP Genotyping SNP Project Rationale Matched Mis-Matched Probe and Target C Allele T Allele • Heritability C Eclipse C C Allele-Specific Hybridization Target G A Dash Hybridize Fail to hybridize Molecular Beacon Affymetrix • Power - Number of Individuals C C C Taqman Target G A Degrade Fail to degrade • Number of SNPs - Candidate Gene, Pathway, Genome 5-10 SNPs, 400 to 1,000, 10K, 500K Fluorescence +ddCTP C Polymerase Extension Target G A Polarization C incorporated C Fails to incorporate Sequenom • DNA requirements C C C SNPlex Oligonucleotide Ligation Target G A Ligate Fail to ligate Parallele • Cost Illumina SNP Typing Formats Defining the scale of the genotyping project is key to selecting an approach: Scale 1000 individuals 5 to 10 SNPs in a candidate gene - Many approaches Microtiter Plates - Fluorescence Low $6,000 (expensive ~ 0.60 per SNP/genotype) eg. Taqman - Good for a few markers - lots of samples - PCR prior to genotyping 48 ( to 96) SNPs in a handful of candidate genes $~29,000 (~ 0.25 to 0.30 per SNP/genotype) Medium Size Analysis by Electrophoresis 384 - 1,536 SNPs - cost reductions based on scale $57,600-122,880 eg. SNPlex - Intermediate Multiplexing (~0.08 - 0.15 per SNP/genotype) reduces costs - Genotype directly on 300,000 to 500,000 SNPs defined format $800,000 genomic DNA - new paradigm for high throughput (~0.002 per SNP/ genotype) Arrays - Custom or Universal High 10,000-20,000 SNPs - defined and custom formats $>250,000 (~0.03 per SNP/genotype) eg. Illumina, ParAllele, Affymetrics - Highly multiplexed - 96, 1,500 SNPs and beyond (500K+) 1 Many Approaches to Genotype a Handful of SNPs Taqman PCR region prior to SNP genotyping - Adds to cost - Many use modified primers - the more modified, Genotyping with fluorescence-based homogenous assays the higher the cost (single-tube assay) = 1 SNP/ tube • Taqman • Single base extension - Fluorescence Polarization Sequenom - Mass Spec • Eclipse • Dash • Molecular Beacons Genotype Calling - Cluster Analysis Genotyping by Mass Spectrometry - 24 SNP 1252 - T SNP 1252 - C SNPlex Assay - 48 SNPs Technological Leap - No advance PCR Universal PCR Priming site Allele Specific Sequence Universal PCR after preparing multiple regions for analysis - ZipCode1 Universal PCR Priming site A P Several based on primer specific on genomic DNA followed by G Locus Specific Sequence PCR of the ligated products - different strategies Genomic ZipCode2 C and different readouts. DNATarget 1. Ligation P SNPlex, Illumina, Parallele (Affymetrix) A Ligation Product G Formed C Also, reduced representation - Affymetrix (Homozygote shown in this case) - cut with restriction enzyme, then ligate linkers 2. Clean-up and amplify from linkers and follow by chip hybridization to read out. 2 PCR & ZipChute Hybridization Detection 3. Multiplexed Universal PCR 9. Characterize on Capillary Sequencer Univ. PCR Primer Biotin Univ. PCR Primer 4. Capture double stranded DNA- microtiter plate SNP 1 (Streptavidin) 5. Denature double stranded DNA 6. Wash away one strand 7. Zip Chute Hybridization • SNP 2 SNPlex Readout Multiplexed Genotyping - Universal Tag Readouts C T A G Locus 1 Specific Sequence Locus 2 Specific Sequence ZipChuten N(n) T Position n Tag1 sequence cTag1 sequence Tag2 sequence cTag2 sequence n ~ 48/lane Substrate Substrate Bead or Chip Bead or Chip ~2000 lanes/day Bead Array Chip Array Zipchute3 NNN T Position 3 ~96,000 genotypes/day Tag 1 Tag 2 Zipchute2 NN A Position 2 Tag 3 Zipchute1 N C Position 1 Tag 4 Multiplex ~96 - 20,000 SNPs Illumina ParAllele Not dependent on primary PCR Affymetrix Arrays - High Density Genotyping Sentrix™ Platform Thousands of SNPs and Beyond • “Bead” Arrays - Illumina – Manufactured by self-assembly – Beads identified by decoding Sentrix™ 96 Multi-array Matrix matches standard microtiter plates (96 - 1536 SNPs/well) Up to ~140,000 assays per matrix 3 Fluorescent Image of BeadArray Illumina Assay - 3 Primers per SNP ~ 3 micron diameter beads Universal forward Sequences (1, 2) ~ 5 micron center- 5’ Universal reverse to-center 3’ sequence G 3’ ~50,000 features (1-20 nt gap) 5’ on ~1.5 mm diameter A Illumicode ™ bundle Allele specific Locus specific Sequence tag Sequence Sequence Currently: up to 1,536 SNPs C genotyped per T Genomic DNA template bundle - at least 30 beads per code - SNP many internal replicates Allele-Specific Extension and GoldenGate™ Assay Ligation Amplification Polymerase Ligase Amplification A illumiCode #561 Genomic DNA [T/C] [T/A] Template Universal A illumiCode’ Address Allele Specific PCR Sequence 1 G Cy3 Universal Extension & Universal Universal Universal PCR with Primer 1 Ligation PCR Sequence 2 PCR Sequence 3’ Common Primer P3 Cy5 Universal Primers Primer 2 Hybridization to Universal IllumiCodeTM BeadArray Reader • Confocal laser scanning system • Resolution, 0.8 micron • Two lasers 532, 635 nm – Supports Cy3 & Cy5 imaging illumiCode illumiCode illumiCode #561 #217 #1024 • Sentrix Arrays (96 bundle) and /\/\/\/ /\/\/\/ /\/\/\/ /\/\/\/ /\/\/\/ Slides for 100k fixed formats A/A T/T C/T 4 Process Controls Illumina Readout for Sentrix Array > 1,000 SNPs Assayed on 96 Samples Mismatch High AT/GC Gender Gap First Hyb Second Hyb Contamination Multiplexed Genotyping - Universal Tag Readouts C T A G Locus 1 Specific Sequence Locus 2 Specific Sequence Parallele - Defined and Custom Formats Tag1 sequence cTag1 sequence Tag2 sequence cTag2 sequence Substrate Substrate Bead or Chip Bead or Chip - Intermediate Strategy Bead Array Chip Array Tag 1 - Multiplex ~ 20,000 SNPs Tag 2 - Affymetrix readout Universal Arrays Tag 3 Tag 4 Multiplex ~96 - 20,000 SNPs Illumina ParAllele Not dependent on primary PCR Affymetrix 5 Parallele Technology (MIP) Molecular Inversion Probes (MIP) Affymetrix’s Chip Whole Genome Association Strategies Two Platforms Available Different Designs - Affymetrix - Illumina 6 500K: Content Optimized SNP Selection ~2,200,000 SNPs • Initial Selection: 48 people ~2,200,000 SNPs – 2.2M SNPs From Public & Perlegen – 25 million genotypes Affymetrix GeneChip Mapping – 16 each Caucasian, African, Asian 48 individuals – All HapMap samples Call rate, concordance • Maximize performance: Second selection 500K Array Set over 400 people ~650K SNPs – 270 HapMap Samples – 130 diversity samples 400 samples – Accuracy Call rate, accuracy • HW, Mendel error, reproducibility – Call rates LD 500K SNPs • Maximize information content: – Prioritize SNPs based on LD & HapMap (Broad Institute) 80% genome coverage of Mapping 500K Mapping 500K Set • 500K run on 270 • >500K SNP’s HapMap samples – 2 array set • Pairwise r2 analysis for common SNPs • Performance (MAF>0.05) – 93-98% call rate range (>95% average) • Robust coverage across – >99.5% concordance with HapMap Genotypes, populations r2=0.8 99.9% reproducibility – CEPH, Asian ~66% • SNP lists, annotation and genotype data available – Yoruba ~45% without restriction at Affymetrix.com • 2 & 3 marker predictors (multimarker) further increase coverage Illumina - Infinium I & II Infinium II Assay 10K - 300K Single Base Extension Two haptens/colors Whole genome amplified DNA Bead U A a T T G G C T G WGA target SNP1 SNP2 SNP3 - - - - - SNP b A-DNP A-DNP C-Bio C-Bio A-DNP C-Bio SNP1 SNP2 SNP3 - - - - - SNP c Signal Green/Red 7 HumanHap-1 Genotyping BeadChip Content HumanHap300 Content Maximize coverage of human variation by choosing tag Strategy SNPs to uniquely identify haplotypes. • Tag SNPs – r2 ≥ 0.80 for bins containing SNPs within 10kb of genes Tag SNP selection process: or in evolutionarily conserved regions (ECRs) 1. Examine HapMap Phase I SNPs with MAF > 0.05 in CEU – r2 ≥ 0.70 for bins containing SNPs outside of genes or ECRs. 2. Bin SNPs in high LD with one another using ldSelect (Carlson, et al. 2004) • Additional Content 3. Select tag SNP with highest design score for each bin. – ~8,000 nsSNPs – ~1,500 tag SNPs selected from high density SNP data in the MHC region • Total 317,503 loci HumanHap300 Data Quality HumanHap300 Genomic Coverage 127 samples by Population 25 trios 1.0 15 replicates 0.9 0.8 Parameter Percent 0.7 0.6 Call rate 99.93% 0.5 0.4 Reproducibility >99.99% 0.3 CEU, mean 0.87 median 0.97 Coverage of Phase I+II Data CHB+JPT, mean 0.80 median 0.94 Mendelian 0.2 YRI, mean 0.57 median 0.55 0.035% 0.1 Inconsistencies 0.0 >0 >0.1 >0.2 >0.3 >0.4 >0.5 >0.6 >0.7 >0.8 >0.9 Concordance with Max r2 99.69% HapMap Data HumanHap500 Content Preliminary HumanHap500 Strategy Genomic Coverage by Population – Analysis of full HapMap data set (Phase I + II) using 1.0 HumanHap300 SNP list 0.9 0.8 – Fill in regions of low LD requiring higher density of tag 0.7 SNPs 0.6 0.5 CEU, mean 0.95 median 1.0 CHB+JPT, mean 0.93 median 1.0 0.4 YRI, mean 0.75 median 0.88 – Content Strategy 0.3 • r2 ≥ 0.80 for bins containing SNPs within 10kb of genes or in Coverage of Phase I+II Loci 0.2 evolutionarily conserved regions (ECRs) in CEU 2 0.1 • r ≥ 0.70 for bins containing SNPs outside of genes or ECRs in CEU 2 0.0 • r ≥ 0.80 for large bins (≥ 3 SNPs) in CHB+JPT population >0 >0.1 >0.2 >0.3 >0.4 >0.5 >0.6 >0.7 >0.8 >0.9 2 • r ≥ 0.70 for large bins (≥ 5 SNPs) in YRI population Max r2 8 Data Quality Control Measuring Error Rates • Genotype replicate Rep 1 • Estimating Error Rates samples CC CT TT • Hardy Weinberg Equilibrium • Error rates generally Rep 2 CC 24 1 0 < <1% • Frequency Analysis CT 0 50 0 • Error rates are SNP • Missing Data TT 0 0 25 specific Measuring Error Rates Replicate samples • Genotype replicate Rep 1 • Replicates can also samples CC CT TT detect sample handling errors • Absolute number of Rep 2 CC 24 1 0 replicates is more – Wrong plate CT 0 50 0 important than – Plate rotation percentage TT 0 0 25 – E.g.
Load more

Recommended publications
  • GENOME GENERATION Glossary
    GENOME GENERATION Glossary Chromosome An organism’s DNA is packaged into chromosomes. Humans have 23 pairs of chromosomesincluding one pair of sex chromosomes. Women have two X chromosomes and men have one X and one Y chromosome. Dominant (see also recessive) Genes come in pairs. A dominant form of a gene is the “stronger” version that will be expressed. Therefore if someone has one dominant and one recessive form of a gene, only the characteristics of the dominant form will appear. DNA DNA is the long molecule that contains the genetic instructions for nearly all living things. Two strands of DNA are twisted together into a double helix. The DNA code is made up of four chemical letters (A, C, G and T) which are commonly referred to as bases or nucleotides. Gene A gene is a section of DNA that is the code for a specific biological component, usually a protein. Each gene may have several alternative forms. Each of us has two copies of most of our genes, one copy inherited from each parent. Most of our traits are the result of the combined effects of a number of different genes. Very few traits are the result of just one gene. Genetic sequence The precise order of letters (bases) in a section of DNA. Genome A genome is the complete DNA instructions for an organism. The human genome contains 3 billion DNA letters and approximately 23,000 genes. Genomics Genomics is the study of genomes. This includes not only the DNA sequence itself, but also an understanding of the function and regulation of genes both individually and in combination.
    [Show full text]
  • Pharmacogenetic Testing: a Tool for Personalized Drug Therapy Optimization
    pharmaceutics Review Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization Kristina A. Malsagova 1,* , Tatyana V. Butkova 1 , Arthur T. Kopylov 1 , Alexander A. Izotov 1, Natalia V. Potoldykova 2, Dmitry V. Enikeev 2, Vagarshak Grigoryan 2, Alexander Tarasov 3, Alexander A. Stepanov 1 and Anna L. Kaysheva 1 1 Biobanking Group, Branch of Institute of Biomedical Chemistry “Scientific and Education Center”, 109028 Moscow, Russia; [email protected] (T.V.B.); [email protected] (A.T.K.); [email protected] (A.A.I.); [email protected] (A.A.S.); [email protected] (A.L.K.) 2 Institute of Urology and Reproductive Health, Sechenov University, 119992 Moscow, Russia; [email protected] (N.V.P.); [email protected] (D.V.E.); [email protected] (V.G.) 3 Institute of Linguistics and Intercultural Communication, Sechenov University, 119992 Moscow, Russia; [email protected] * Correspondence: [email protected]; Tel.: +7-499-764-9878 Received: 2 November 2020; Accepted: 17 December 2020; Published: 19 December 2020 Abstract: Pharmacogenomics is a study of how the genome background is associated with drug resistance and how therapy strategy can be modified for a certain person to achieve benefit. The pharmacogenomics (PGx) testing becomes of great opportunity for physicians to make the proper decision regarding each non-trivial patient that does not respond to therapy. Although pharmacogenomics has become of growing interest to the healthcare market during the past five to ten years the exact mechanisms linking the genetic polymorphisms and observable responses to drug therapy are not always clear. Therefore, the success of PGx testing depends on the physician’s ability to understand the obtained results in a standardized way for each particular patient.
    [Show full text]
  • HIV Genotyping and Phenotyping AHS – M2093
    Corporate Medical Policy HIV Genotyping and Phenotyping AHS – M2093 File Name: HIV_genotyping_and_phenotyping Origination: 1/2019 Last CAP Review: 2/2021 Next CAP Review: 2/2022 Last Review: 2/2021 Description of Procedure or Service Description Human immunodeficiency virus (HIV) is an RNA retrovirus that infects human immune cells (specifically CD4 cells) causing progressive deterioration of the immune system ultimately leading to acquired immune deficiency syndrome (AIDS) characterized by susceptibility to opportunistic infections and HIV-related cancers (CDC, 2014). Related Policies Plasma HIV-1 and HIV-2 RNA Quantification for HIV Infection Scientific Background Human immunodeficiency virus (HIV) targets the immune system, eventually hindering the body’s ability to fight infections and diseases. If not treated, an HIV infection may lead to acquired immunodeficiency syndrome (AIDS) which is a condition caused by the virus. There are two main types of HIV: HIV-1 and HIV-2; both are genetically different. HIV-1 is more common and widespread than HIV-2. HIV replicates rapidly; a replication cycle rate of approximately one to two days ensures that after a single year, the virus in an infected individual may be 200 to 300 generations removed from the initial infection-causing virus (Coffin & Swanstrom, 2013). This leads to great genetic diversity of each HIV infection in a single individual. As an RNA retrovirus, HIV requires the use of a reverse transcriptase for replication purposes. A reverse transcriptase is an enzyme which generates complimentary DNA from an RNA template. This enzyme is error-prone with the overall single-step point mutation rate reaching ∼3.4 × 10−5 mutations per base per replication cycle (Mansky & Temin, 1995), leading to approximately one genome in three containing a mutation after each round of replication (some of which confer drug resistance).
    [Show full text]
  • Review of the Current State of Genetic Testing - a Living Resource
    Review of the Current State of Genetic Testing - A Living Resource Prepared by Liza Gershony, DVM, PhD and Anita Oberbauer, PhD of the University of California, Davis Editorial input by Leigh Anne Clark, PhD of Clemson University July, 2020 Contents Introduction .................................................................................................................................................. 1 I. The Basics ......................................................................................................................................... 2 II. Modes of Inheritance ....................................................................................................................... 7 a. Mendelian Inheritance and Punnett Squares ................................................................................. 7 b. Non-Mendelian Inheritance ........................................................................................................... 10 III. Genetic Selection and Populations ................................................................................................ 13 IV. Dog Breeds as Populations ............................................................................................................. 15 V. Canine Genetic Tests ...................................................................................................................... 16 a. Direct and Indirect Tests ................................................................................................................ 17 b. Single
    [Show full text]
  • Evaluation of Openarray™ As a Genotyping Method for Forensic DNA Phenotyping and Human Identification
    G C A T T A C G G C A T genes Article Evaluation of OpenArray™ as a Genotyping Method for Forensic DNA Phenotyping and Human Identification Michele Ragazzo 1, Giulio Puleri 1, Valeria Errichiello 1, Laura Manzo 1, Laura Luzzi 1 , Saverio Potenza 2 , Claudia Strafella 1,3 , Cristina Peconi 3, Fabio Nicastro 4 , Valerio Caputo 1 and Emiliano Giardina 1,3,* 1 Department of Biomedicine and Prevention, Tor Vergata University of Rome, 00133 Rome, Italy; [email protected] (M.R.); [email protected] (G.P.); [email protected] (V.E.); [email protected] (L.M.); [email protected] (L.L.); [email protected] (C.S.); [email protected] (V.C.) 2 Department of Biomedicine and Prevention, Section of Legal Medicine, Social Security and Forensic Toxicology, University of Rome Tor Vergata, 00133 Rome, Italy; [email protected] 3 Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, 00179 Rome, Italy; [email protected] 4 Austech, 00153 Rome, Italy; [email protected] * Correspondence: [email protected] Abstract: A custom plate of OpenArray™ technology was evaluated to test 60 single-nucleotide polymorphisms (SNPs) validated for the prediction of eye color, hair color, and skin pigmentation, and for personal identification. The SNPs were selected from already validated subsets (Hirisplex-s, Precision ID Identity SNP Panel, and ForenSeq DNA Signature Prep Kit). The concordance rate and call rate for every SNP were calculated by analyzing 314 sequenced DNA samples. The sensitivity of the assay was assessed by preparing a dilution series of 10.0, 5.0, 1.0, and 0.5 ng.
    [Show full text]
  • Genotyping-By-Sequencing to Unlock Genetic Diversity and Population Structure in White Yam (Dioscorea Rotundata Poir.)
    agronomy Article Genotyping-by-Sequencing to Unlock Genetic Diversity and Population Structure in White Yam (Dioscorea rotundata Poir.) Ranjana Bhattacharjee 1,* , Paterne Agre 1 , Guillaume Bauchet 2, David De Koeyer 3, Antonio Lopez-Montes 1,4, P. Lava Kumar 1 , Michael Abberton 1, Patrick Adebola 5, Asrat Asfaw 5 and Robert Asiedu 1 1 International Institute of Tropical Agriculture, PMB 5320, Ibadan 200001, Nigeria; [email protected] (P.A.); [email protected] (A.L.-M.); [email protected] (P.L.K.); [email protected] (M.A.); [email protected] (R.A.) 2 Boyce Thompson Institute, Cornell University, Ithaca, NY 14853, USA; [email protected] 3 Agriculture and Agri-Food Canada, Fredericton, NB E3B 4Z7, Canada; [email protected] 4 International Trade Center, 29 Independence Avenue, Accra 00233, Ghana 5 International Institute of Tropical Agriculture, PMB 82, Kubuwa, Abuja 901101, Nigeria; [email protected] (P.A.); [email protected] (A.A.) * Correspondence: [email protected] Received: 7 August 2020; Accepted: 14 September 2020; Published: 22 September 2020 Abstract: White yam (Dioscorea rotundata Poir.) is one of the most important tuber crops in West Africa, where it is indigenous and represents the largest repository of biodiversity through several years of domestication, production, consumption, and trade. In this study, the genotyping-by-sequencing (GBS) approach was used to sequence 814 genotypes consisting of genebank landraces, breeding lines, and market varieties to understand the level of genetic diversity and pattern of the population structure among them. The genetic diversity among different genotypes was assessed using three complementary clustering methods, the model-based admixture, discriminant analysis of principal components (DAPC), and phylogenetic tree.
    [Show full text]
  • DNA Phenotyping and Kinship Determination
    DNA Phenotyping and Kinship Determination Ellen McRae Greytak, PhD Director of Bioinformatics Parabon NanoLabs, Inc. ©©2 2015015 ParabonParabon NanoLabs,NanoLabs Inc.Inc All rightsrights reserved. reserved Forensic Applications of DNA Phenotyping Predict a person’s ancestry and/or appearance (“phenotype”) from his or her DNA Generate investigative leads when DNA doesn’t match a database (e.g., CODIS) Gain additional information (e.g., pigmentation, detailed ancestry) about unidentified remains Main value is in excluding non-matching individuals to help narrow a suspect list Without information on age, weight, lifestyle, etc., phenotyping currently is not targeted toward individual identification Snapshot Workflow Workflow of a Parabon® Snapshot™ Investigation Unidentified Remains DNA Evidence Is Collected and Sent to Crime Lab DNA Evidence DNA Crime Lab CCrime Lab Extracts DNA And Produces STR Profile Checked STR Profile (a.k.a. “DNA Fingerprint”) AAgainst DNA Database(s) Yes Match No Found? SnapshotS Composite Ordered Extracted DNA ™ D N A PH E N O T Y P I N G DNA Service Labs Unidentified DNA Is Genotype Data Is Genotyping Lab Produces SNP Sent To Service Lab Sent To Parabon Profile (a.k.a. “DNA Blueprint”) (DNA Extracted If Needed) 50pg – 2ng DNA Evidence — or — Extracted DNA NOTE: STR Profiles Do Not Contain Sufficient Genetic Information to Produce A SNP Genotype Parabon NanoLabs PParabonb AnalyzesAl PParabon Predicts Physical Traits Investigator Uses Genotype Data and Produces Snapshot Report
    [Show full text]
  • Genotyping of Single Nucleotide Polymorphisms Using Allele
    diagnostics Article Genotyping of Single Nucleotide Polymorphisms Using Allele-Specific qPCR Producing Amplicons of Small Sizes Directly from Crude Serum Isolated from Capillary Blood by a Hand-Powered Paper Centrifuge Gustavo Barcelos Barra 1,2,*,† , Ticiane Henriques Santa Rita 1,2,†, Daniella Paniago Jardim 1,2,†, Pedro Góes Mesquita 1, Camila Santos Nobre 1,2, Rafael Henriques Jácomo 1 and Lídia Freire Abdalla Nery 1 1 Sabin Laboratory, Brasília 70632-300, Brazil; [email protected] (T.H.S.R.); [email protected] (D.P.J.); [email protected] (P.G.M.); [email protected] (C.S.N.); [email protected] (R.H.J.); [email protected] (L.F.A.N.) 2 Post-Graduation of Health Science, University of Brasília, Brasilia 70910-900, Brazil * Correspondence: [email protected] † These authors contributed equally to the study. Received: 15 November 2018; Accepted: 29 December 2018; Published: 11 January 2019 Abstract: The cell-free genomic DNA (gDNA) concentration in serum ranges from 1500 to 7500 copies/mL within 2 h after phlebotomy (6–24 times the concentration observed in plasma). Here, we aimed to evaluate the gDNA size distribution in serum with time after coagulation and to test if crude serum can be directly used as a source of gDNA for qPCR. Next, we investigated if single nucleotide polymorphisms (SNPs) could be genotyped directly from the crude serum isolated from capillary blood using a hand-powered paper centrifuge. All tested PCR targets (65, 100, 202 and 688 base pairs) could be successfully amplified from DNA extracted from serum, irrespective of their amplicon size.
    [Show full text]
  • Molecular Methods for Bacterial Genotyping and Analyzed Gene Regions
    42Journal of Microbiology and Infectious DiseasesYıldırım / İH et al. Molecular methods 2011; 1 (1): 42-46 JMID doi: 10.5799/ahinjs.02.2011.01.0011 REVIEW ARTICLE Molecular methods for bacterial genotyping and analyzed gene regions İbrahim Halil Yıldırım1, Seval Cing Yıldırım2, Nadir Koçak3 1Dicle University, Faculty of Veterinary Department of Genetics, Diyarbakır, Turkey 2İnönü University, Faculty of Science, Department of Biology, Malatya, Turkey 3Selçuk University, Selçuklu Medical Faculty, Department of Medical Genetics, Konya, Turkey ABSTRACT Bacterial strain typing is an important process for diagnosis, treatment and epidemiological investigations. Current bacterial strain typing methods may be classified into two main categories: phenotyping and genotyping. Phenotypic characters are the reflection of genetic contents. Genotyping, which refers discrimination of bacterial strains based on their genetic content, has recently become widely used for bacterial strain typing. The methods already used in geno- typing of bacteria are quite different from each other. In this review we tried to summarize the basic principles of DNA- based methods used in genotyping of bacteria and describe some important DNA regions that are used in genotyping of bacteria. J Microbiol Infect Dis 2011;1(1):42-46. Key words: Bacterial genotyping, pulsed-field gel electrophoresis, internal transcribed region (ITS) Bakteri genotiplendirmesinde kullanılan moleküler yöntemler ve incelenen gen bölgeleri ÖZET Bakteri tiplendirilmesi tanı, tedavi ve epidemiyolojik araştırmalar için önemli bir süreçtir. Mevcut bakteriyal suş tiplendir- me yöntemleri iki ana kategoride sınıflandırılabilir: fenotipleme ve genotipleme. Fenotipik karakterler genetik içeriğin yansımasıdır. Bakterilerin genetik içeriklerine bağlı olarak sınıflandırılması olan genotiplendirme son dönemlerde bak- teri tiplendirmesinde sıklıkla kullanılmaktadır. Bakteri genotiplendirmesinde kullanılan yöntemler birbirlerinden oldukça farklıdır.
    [Show full text]
  • Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling
    Guidance for Industry Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH) January 2013 Clinical Pharmacology Clinical/Medical 10300.fnl.doc Guidance for Industry Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling Additional copies are available from: Office of Communications Division of Drug Information, WO51, Room 2201 10903 New Hampshire Ave. Silver Spring, MD 20993-0002 Phone: 301-796-3400; Fax 301-847-8714 http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm or Office of Communication, Outreach, and Development (HFM-40) Center for Biologics Evaluation and Research Food and Drug Administration 1401 Rockville Pike, Rockville, MD 20852-1448 http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm (Tel) 800-835-4709 or 301-827-1800 or Office of Communication, Education, and Radiation Programs Division of Small Manufacturers, International and Consumer Assistance Center for Devices and Radiological Health Food and Drug Administration 10903 New Hampshire Ave. WO66, Room 4613 Silver Spring, MD 20993-0002 http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm Email: [email protected] Fax: 301-827-8149 (Tel) Manufacturers Assistance: 800-638-2041 or 301-796-7100 (Tel) International Staff: 301-796-5708 U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH) January 2013 Clinical Pharmacology Clinical/Medical TABLE OF CONTENTS I.
    [Show full text]
  • Genotyping Bacterial and Fungal Pathogens Using Sequence Variation in the Gene for the CCA-Adding Enzyme Paul Franz, Heike Betat and Mario Mörl*
    Franz et al. BMC Microbiology (2016) 16:47 DOI 10.1186/s12866-016-0670-2 METHODOLOGY ARTICLE Open Access Genotyping bacterial and fungal pathogens using sequence variation in the gene for the CCA-adding enzyme Paul Franz, Heike Betat and Mario Mörl* Abstract Background: To allow an immediate treatment of an infection with suitable antibiotics and bactericides or fungicides, there is an urgent need for fast and precise identification of the causative human pathogens. Methods based on DNA sequence comparison like 16S rRNA analysis have become standard tools for pathogen verification. However, the distinction of closely related organisms remains a challenging task. To overcome such limitations, we identified a new genomic target sequence located in the single copy gene for tRNA nucleotidyltransferase fulfilling the requirements for a ubiquitous, yet highly specific DNA marker. In the present study, we demonstrate that this sequence marker has a higher discriminating potential than commonly used genotyping markers in pro- as well as eukaryotes, underscoring its applicability as an excellent diagnostic tool in infectology. Results: Based on phylogenetic analyses, a region within the gene for tRNA nucleotidyltransferase (CCA-adding enzyme) was identified as highly heterogeneous. As prominent examples for pro- and eukaryotic pathogens, several Vibrio and Aspergillus species were used for genotyping and identification in a multiplex PCR approach followed by gel electrophoresis and fluorescence-based product detection. Compared to rRNA analysis, the selected gene region of the tRNA nucleotidyltransferase revealed a seven to 30-fold higher distinction potential between closely related Vibrio or Aspergillus species, respectively. The obtained data exhibit a superb genome specificity in the diagnostic analysis.
    [Show full text]
  • Single Nucleotide Polymorphism Genotyping: Biochemistry, Protocol, Cost and Throughput
    The Pharmacogenomics Journal (2003) 3, 77–96 & 2003 Nature Publishing Group All rights reserved 1470-269X/03 $25.00 www.nature.com/tpj REVIEW Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput X Chen ABSTRACT The large number of single nucleotide polymorphism (SNP) markers available PF Sullivan in the public databases makes studies of association and fine mapping of Department of Psychiatry, Virginia Institute for disease loci very practical. To provide information for researchers who do not Psychiatric and Behavioral Genetics, Virginia follow SNP genotyping technologies but need to use them for their research, Commonwealth University, Richmond, VA, USA we review here recent developments in the fields. We start with a general description of SNP typing protocols and follow this with a summary of Correspondence: current methods for each step of the protocol and point out the unique Dr X Chen, Department of Psychiatry, Virginia Institute for Psychiatric and features and weaknesses of these techniques as well as comparing the cost Behavioral Genetics, Virginia and throughput structures of the technologies. Finally, we describe some Commonwealth University, 800 E. Leigh popular techniques and the applications that are suitable for these Street, Richmond, VA 23298-0424, USA Tel: techniques. +1 804 828 8124 Fax: +1 804 828 3223 E-mail: [email protected] The Pharmacogenomics Journal (2003) 3, 77–96. doi:10.1038/sj.tpj.6500167 Keywords: SNP; genotyping; allele discrimination; cost; throughput INTRODUCTION Single nucleotide polymorphisms (SNPs) have emerged as genetic markers of choice because of their high-density and relatively even distribution in the human genomes1–3 and have been used by many groups for fine mapping disease loci and for candidate gene association studies.
    [Show full text]